Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.
- DOI
- 10.1158/1535-7163.mct-19-0482
- Published
- 2020 Aug
- Container
- Molecular cancer therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-19-0482,
title = {Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.},
author = {Chen R and Rajan S and Overstreet MG and Hurt EM and Thomas SB and Muniz-Medina V and Ward C and Sadowska A and Fleming R and Karanth S and Breen S and Zheng B and Wu Y and Iverson WO and Novick S and O'Day T and Shah DP and Dimasi N and Tiberghien AC and Osbourn J and Walker J},
year = {2020},
journal = {Molecular cancer therapeutics},
doi = {10.1158/1535-7163.mct-19-0482},
url = {https://doi.org/10.1158/1535-7163.mct-19-0482}
}RIS
TY - JOUR TI - Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells. AU - Chen R AU - Rajan S AU - Overstreet MG AU - Hurt EM AU - Thomas SB AU - Muniz-Medina V AU - Ward C AU - Sadowska A AU - Fleming R AU - Karanth S AU - Breen S AU - Zheng B AU - Wu Y AU - Iverson WO AU - Novick S AU - O'Day T AU - Shah DP AU - Dimasi N AU - Tiberghien AC AU - Osbourn J AU - Walker J PY - 2020 JO - Molecular cancer therapeutics DO - 10.1158/1535-7163.mct-19-0482 UR - https://doi.org/10.1158/1535-7163.mct-19-0482 ER -
APA
R, C., S, R., MG, O., EM, H., SB, T., V, M., C, W., A, S., R, F., S, K., S, B., B, Z., Y, W., WO, I., S, N., T, O., DP, S., N, D., AC, T., J, O., & J, W. (2020). Preclinical Characterization of an Antibody-Drug Conjugate Targeting CS-1 and the Identification of Uncharacterized Populations of CS-1-Positive Cells.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-19-0482
Source records
- pubmed · retrieved 2026-09-27T00:45:23.244Z